A. “Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed),” (PAR-20-055, a reissue of of PAR-16-398, National Institute on Aging, in conjunction with other agenices, application deadlines Feb. 5, June, 5, and Oct. 5). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed),” (PAR-20-082).
grants.nih.gov/grants/guide/pa-files/PAR-20-055.html
B. “BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional),” (RFA-NS-20-006, a reissue of RFA-NS-18-018, National Institute on Aging, in conjunction with other agenices, application deadlines March 24, 2020, June 2, 2020, October 1, 2020, February 2, 2021, June 1, 2021, October 1, 2021, February 1, 2022, June 1, 2022, and October 3, 2022).
grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-006.html
C. “White Matter Lesion Etiology of Dementia in the U.S. Including in Health Disparity Populations (U19 Clinical Trial not Allowed),” (RFA-NS-20-013, National Institute on Aging, in conjunction with other agenices, application deadlines, March 31, 2020).
grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-013.html
D. “Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed),” (PAR-20-055, a reissue of PAR-16-398, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed),” (PAR-20-082).
